Literature DB >> 24344131

CCAAT/enhancer-binding protein β regulates the repression of type II collagen expression during the differentiation from proliferative to hypertrophic chondrocytes.

Takahiro Ushijima1, Ken Okazaki, Hidetoshi Tsushima, Yukihide Iwamoto.   

Abstract

CCAAT/enhancer-binding protein β (C/EBPβ) is a transcription factor that promotes hypertrophic differentiation by stimulating type X collagen and matrix metalloproteinase 13 during chondrocyte differentiation. However, the effect of C/EBPβ on proliferative chondrocytes is unclear. Here, we investigated whether C/EBPβ represses type II collagen (COL2A1) expression and is involved in the regulation of sex-determining region Y-type high mobility group box 9 (SOX9), a crucial factor for transactivation of Col2a1. Endogenous expression of C/EBPβ in the embryonic growth plate and differentiated ATDC5 cells were opposite to those of COL2A1 and SOX9. Overexpression of C/EBPβ by adenovirus vector in ATDC5 cells caused marked repression of Col2a1. The expression of Sox9 mRNA and nuclear protein was also repressed, resulting in decreased binding of SOX9 to the Col2a1 enhancer as shown by a ChIP assay. Knockdown of C/EBPβ by lentivirus expressing shRNA caused significant stimulation of these genes in ATDC5 cells. Reporter assays demonstrated that C/EBPβ repressed transcriptional activity of Col2a1. Deletion and mutation analysis showed that the C/EBPβ core responsive element was located between +2144 and +2152 bp within the Col2a1 enhancer. EMSA and ChIP assays also revealed that C/EBPβ directly bound to this region. Ex vivo organ cultures of mouse limbs transfected with C/EBPβ showed that the expression of COL2A1 and SOX9 was reduced upon ectopic C/EBPβ expression. Together, these results indicated that C/EBPβ represses the transcriptional activity of Col2a1 both directly and indirectly through modulation of Sox9 expression. This consequently promotes the phenotypic conversion from proliferative to hypertrophic chondrocytes during chondrocyte differentiation.

Entities:  

Keywords:  C/EBP Transcription Factor; Chondrocytes; Collagen; Differentiation; Osteoarthritis

Mesh:

Substances:

Year:  2013        PMID: 24344131      PMCID: PMC3908417          DOI: 10.1074/jbc.M113.492843

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site.

Authors:  Haruhiko Akiyama; Tetsu Kamitani; Xiaohong Yang; Roshini Kandyil; Laura C Bridgewater; Marc Fellous; Yuko Mori-Akiyama; Benoit de Crombrugghe
Journal:  Matrix Biol       Date:  2004-12-08       Impact factor: 11.583

2.  SOX9 directly regulates the type-II collagen gene.

Authors:  D M Bell; K K Leung; S C Wheatley; L J Ng; S Zhou; K W Ling; M H Sham; P Koopman; P P Tam; K S Cheah
Journal:  Nat Genet       Date:  1997-06       Impact factor: 38.330

3.  The transcription factor Sox9 is involved in BMP-2 signaling.

Authors:  B K Zehentner; C Dony; H Burtscher
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

4.  OP-1 (BMP-7) affects mRNA expression of type I, II, X collagen, and matrix Gla protein in ossifying long bones in vitro.

Authors:  A Haaijman; R N D'Souza; A L Bronckers; S W Goei; E H Burger
Journal:  J Bone Miner Res       Date:  1997-11       Impact factor: 6.741

5.  SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene.

Authors:  V Lefebvre; W Huang; V R Harley; P N Goodfellow; B de Crombrugghe
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

6.  C/EBPβ and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2α as the inducer in chondrocytes.

Authors:  Makoto Hirata; Fumitaka Kugimiya; Atsushi Fukai; Taku Saito; Fumiko Yano; Toshiyuki Ikeda; Akihiko Mabuchi; Bishwa Raj Sapkota; Toru Akune; Nao Nishida; Noriko Yoshimura; Takumi Nakagawa; Katsushi Tokunaga; Kozo Nakamura; Ung-il Chung; Hiroshi Kawaguchi
Journal:  Hum Mol Genet       Date:  2011-11-17       Impact factor: 6.150

7.  Sox9 is required for cartilage formation.

Authors:  W Bi; J M Deng; Z Zhang; R R Behringer; B de Crombrugghe
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

8.  Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice.

Authors:  V Lefebvre; S Garofalo; G Zhou; M Metsäranta; E Vuorio; B De Crombrugghe
Journal:  Matrix Biol       Date:  1994-08       Impact factor: 11.583

9.  Design of a C/EBP-specific, dominant-negative bZIP protein with both inhibitory and gain-of-function properties.

Authors:  M Olive; S C Williams; C Dezan; P F Johnson; C Vinson
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

10.  Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor.

Authors:  C Shukunami; C Shigeno; T Atsumi; K Ishizeki; F Suzuki; Y Hiraki
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

View more
  16 in total

1.  Sirtuin-1 (SIRT1) stimulates growth-plate chondrogenesis by attenuating the PERK-eIF-2α-CHOP pathway in the unfolded protein response.

Authors:  Xiaomin Kang; Wei Yang; Ruiqi Wang; Tianping Xie; Huixia Li; Dongxu Feng; Xinxin Jin; Hongzhi Sun; Shufang Wu
Journal:  J Biol Chem       Date:  2018-04-13       Impact factor: 5.157

Review 2.  Transcriptional network systems in cartilage development and disease.

Authors:  Riko Nishimura; Kenji Hata; Eriko Nakamura; Tomohiko Murakami; Yoshifumi Takahata
Journal:  Histochem Cell Biol       Date:  2018-01-08       Impact factor: 4.304

3.  Histone deacetylase inhibitor vorinostat (SAHA, MK0683) perturb miR-9-MCPIP1 axis to block IL-1β-induced IL-6 expression in human OA chondrocytes.

Authors:  Mohammad S Makki; Tariq M Haqqi
Journal:  Connect Tissue Res       Date:  2016-07-12       Impact factor: 3.417

Review 4.  Determinants of stem cell lineage differentiation toward chondrogenesis versus adipogenesis.

Authors:  Sheng Zhou; Song Chen; Qing Jiang; Ming Pei
Journal:  Cell Mol Life Sci       Date:  2019-01-28       Impact factor: 9.261

5.  Identification and Functional Characterization of RSPO2 as a Susceptibility Gene for Ossification of the Posterior Longitudinal Ligament of the Spine.

Authors:  Masahiro Nakajima; Ikuyo Kou; Hirofumi Ohashi; Shiro Ikegawa
Journal:  Am J Hum Genet       Date:  2016-06-30       Impact factor: 11.025

6.  Transcription factors related to chondrogenesis in pleomorphic adenoma of the salivary gland: a mechanism of mesenchymal tissue formation.

Authors:  Yuka Matsumoto; Sunao Sato; Takashi Maeda; Mitsunobu Kishino; Satoru Toyosawa; Yu Usami; So-ichi Iwai; Mitsuhiro Nakazawa; Yoshiaki Yura; Yuzo Ogawa
Journal:  Lab Invest       Date:  2015-10-26       Impact factor: 5.662

7.  XBP1-Independent UPR Pathways Suppress C/EBP-β Mediated Chondrocyte Differentiation in ER-Stress Related Skeletal Disease.

Authors:  Trevor L Cameron; Katrina M Bell; Irma L Gresshoff; Lisa Sampurno; Lorna Mullan; Joerg Ermann; Laurie H Glimcher; Raymond P Boot-Handford; John F Bateman
Journal:  PLoS Genet       Date:  2015-09-15       Impact factor: 5.917

8.  CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.

Authors:  Hidetoshi Tsushima; Ken Okazaki; Kohei Ishihara; Takahiro Ushijima; Yukihide Iwamoto
Journal:  Arthritis Res Ther       Date:  2015-02-17       Impact factor: 5.156

9.  CCAAT/enhancer binding protein β regulates expression of Indian hedgehog during chondrocytes differentiation.

Authors:  Takahiro Ushijima; Ken Okazaki; Hidetoshi Tsushima; Kohei Ishihara; Toshio Doi; Yukihide Iwamoto
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

10.  SOCS1 suppresses IL-1β-induced C/EBPβ expression via transcriptional regulation in human chondrocytes.

Authors:  You-Jung Ha; Yong Seok Choi; Eun Ha Kang; Kichul Shin; Tae Kyun Kim; Yeong Wook Song; Yun Jong Lee
Journal:  Exp Mol Med       Date:  2016-06-24       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.